FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020097637> ?p ?o ?g. }

• W2020097637 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCChk1 kinase is a key component of the DNA damage checkpoint pathway and inhibitors have been developed to sensitize cell killing by genotoxic agents. UCN-01 and related Chk1 inhibitors abrogate DNA damage checkpoint arrest that results in mitotic catastrophe. We have characterized the mitotic defects of cells that were treated with genotoxic agents alone and in combination with Chk1 inhibition. Gemcitabine is used to treat pancreatic cancer and studies have shown that cell killing can be enhanced by Chk1 inhibitors. PANC-1 cells expressing GFP:H2B were monitored by FACs and time-lapse microscopy after treatment with gemcitabine and UCN-01. Gemcitabine induced an S phase arrest for as long as 48h. Addition of UCN-01 to S phase arrested cells promoted entry into mitosis. The morphology of the chromosomes was highly abnormal and cells were delayed in mitosis for many hours. Staining for centromere (ACA) and kinetochore (CENP-F) markers revealed that these structures appeared to be detached from the bulk of the chromatin mass, which tended to be excluded outside of the bipolar spindle. Electron microscopy of gemcitabine + UCN-01 treated cells revealed unpaired kinetochore fragments that were detached from the chromosome. These structures were reminiscent of those seen in rodent CHO cells that underwent ‘mitosis with unreplicated genomes’ (MUGs). Analysis of additional pancreatic tumor cell lines for their responses to gemcitabine + UCN-01 showed that MiaPaCaII cells MUGged but others (CFPAC and BXPC3) did not. We next tested whether insensitivity of the non-responders to UCN-01 was due to limiting factors required for the S/G2 transition or the G2/M transition. CFPAC and BXPC3 cells that were arrested in G2 with MMS or topoII inhibitors were able to enter mitosis after UCN-01 treatment. For these cells, inhibition of Chk1 is not sufficient to overcome the gemcitabine-induced S phase arrest. We discovered that kinetochore fragmentation (MUGging) resulting from Chk1 inhibition is not restricted to replication inhibitors such as gemcitabine. Intriguingly, Chk1 override of topoisomerase II inhibitor-induced G2 arrest generated MUG's in all cell lines tested, regardless of their response to gemcitabine. EM studies show the presence of detached kinetochore fragments consistent with the MUG's observed after gemcitabine+UCN-01 treatment. Our findings suggest that centromere and kinetochore fragmentation is a major mechanism by which Chk1 inhibitors sensitize cells to killing by genotoxic agents. Detachment of centromeres from chromosomes results in death of cells while arrested in mitosis. Cells that exit mitosis are multinucleated and are not clonogenically viable. Due to the sensitization of cell death when cells are forced to MUG, we propose that inhibiting Chk1 after chemotherapies that induce centromere defects such as DNA replication or DNA topology inhibitors represents a beneficial therapeutic strategy.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2511." @default.
• W2020097637 created "2016-06-24" @default.
• W2020097637 creator A5056366467 @default.
• W2020097637 creator A5078553957 @default.
• W2020097637 creator A5088763053 @default.
• W2020097637 date "2010-04-15" @default.
• W2020097637 modified "2023-09-25" @default.
• W2020097637 title "Abstract 2511: Differential cell cycle-dependent Chk1 inhibitor sensitization of genotoxic agents" @default.
• W2020097637 doi "https://doi.org/10.1158/1538-7445.am10-2511" @default.
• W2020097637 hasPublicationYear "2010" @default.
• W2020097637 type Work @default.
• W2020097637 sameAs 2020097637 @default.
• W2020097637 citedByCount "0" @default.
• W2020097637 crossrefType "proceedings-article" @default.
• W2020097637 hasAuthorship W2020097637A5056366467 @default.
• W2020097637 hasAuthorship W2020097637A5078553957 @default.
• W2020097637 hasAuthorship W2020097637A5088763053 @default.
• W2020097637 hasConcept C105696609 @default.
• W2020097637 hasConcept C121608353 @default.
• W2020097637 hasConcept C1491633281 @default.
• W2020097637 hasConcept C153911025 @default.
• W2020097637 hasConcept C175732170 @default.
• W2020097637 hasConcept C185592680 @default.
• W2020097637 hasConcept C186000732 @default.
• W2020097637 hasConcept C2777563682 @default.
• W2020097637 hasConcept C2780258809 @default.
• W2020097637 hasConcept C29537977 @default.
• W2020097637 hasConcept C47432576 @default.
• W2020097637 hasConcept C502942594 @default.
• W2020097637 hasConcept C54355233 @default.
• W2020097637 hasConcept C552990157 @default.
• W2020097637 hasConcept C83640560 @default.
• W2020097637 hasConcept C85813293 @default.
• W2020097637 hasConcept C86803240 @default.
• W2020097637 hasConcept C93304396 @default.
• W2020097637 hasConcept C95444343 @default.
• W2020097637 hasConceptScore W2020097637C105696609 @default.
• W2020097637 hasConceptScore W2020097637C121608353 @default.
• W2020097637 hasConceptScore W2020097637C1491633281 @default.
• W2020097637 hasConceptScore W2020097637C153911025 @default.
• W2020097637 hasConceptScore W2020097637C175732170 @default.
• W2020097637 hasConceptScore W2020097637C185592680 @default.
• W2020097637 hasConceptScore W2020097637C186000732 @default.
• W2020097637 hasConceptScore W2020097637C2777563682 @default.
• W2020097637 hasConceptScore W2020097637C2780258809 @default.
• W2020097637 hasConceptScore W2020097637C29537977 @default.
• W2020097637 hasConceptScore W2020097637C47432576 @default.
• W2020097637 hasConceptScore W2020097637C502942594 @default.
• W2020097637 hasConceptScore W2020097637C54355233 @default.
• W2020097637 hasConceptScore W2020097637C552990157 @default.
• W2020097637 hasConceptScore W2020097637C83640560 @default.
• W2020097637 hasConceptScore W2020097637C85813293 @default.
• W2020097637 hasConceptScore W2020097637C86803240 @default.
• W2020097637 hasConceptScore W2020097637C93304396 @default.
• W2020097637 hasConceptScore W2020097637C95444343 @default.
• W2020097637 hasLocation W20200976371 @default.
• W2020097637 hasOpenAccess W2020097637 @default.
• W2020097637 hasPrimaryLocation W20200976371 @default.
• W2020097637 hasRelatedWork W1481448481 @default.
• W2020097637 hasRelatedWork W1579038875 @default.
• W2020097637 hasRelatedWork W1974788629 @default.
• W2020097637 hasRelatedWork W1974861105 @default.
• W2020097637 hasRelatedWork W1993897258 @default.
• W2020097637 hasRelatedWork W2001777926 @default.
• W2020097637 hasRelatedWork W2031683541 @default.
• W2020097637 hasRelatedWork W2047383934 @default.
• W2020097637 hasRelatedWork W2052287702 @default.
• W2020097637 hasRelatedWork W2082153614 @default.
• W2020097637 hasRelatedWork W2141306016 @default.
• W2020097637 hasRelatedWork W2145668050 @default.
• W2020097637 hasRelatedWork W2546458004 @default.
• W2020097637 hasRelatedWork W2736626145 @default.
• W2020097637 hasRelatedWork W2930487945 @default.
• W2020097637 hasRelatedWork W2967930238 @default.
• W2020097637 hasRelatedWork W3137323461 @default.
• W2020097637 hasRelatedWork W3190320095 @default.
• W2020097637 hasRelatedWork W62825502 @default.
• W2020097637 hasRelatedWork W1627260149 @default.
• W2020097637 isParatext "false" @default.
• W2020097637 isRetracted "false" @default.
• W2020097637 magId "2020097637" @default.
• W2020097637 workType "article" @default.